{"id":55286,"date":"2024-01-27T15:56:38","date_gmt":"2024-01-27T15:56:38","guid":{"rendered":"https:\/\/medsname.com\/anaridex\/"},"modified":"2026-04-30T10:24:49","modified_gmt":"2026-04-30T10:24:49","slug":"anaridex","status":"publish","type":"product","link":"https:\/\/medsbase.com\/el\/anaridex\/","title":{"rendered":"Anaridex"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Anaridex?<\/h3>\n<p style=\"margin:0;\"><strong>Anaridex<\/strong> is an oral tablet from Cipla containing <strong>anastrozole 1 mg<\/strong> &mdash; a selective <strong>third-generation aromatase inhibitor<\/strong>. First-line adjuvant and metastatic therapy for <strong>hormone-receptor-positive breast cancer in postmenopausal women<\/strong>. Standard dose: <strong>1 mg once daily<\/strong>, typically for <strong>5&ndash;10 years<\/strong> in adjuvant setting. Anastrozole works by blocking conversion of androgens to oestrogen in peripheral tissue (~95% suppression). <strong>Postmenopausal women only<\/strong> &mdash; ineffective in premenopausal women (use <a href=\"https:\/\/medsbase.com\/el\/tamilong\/\">tamoxifen<\/a> instead). Main side effects: hot flushes, joint and muscle pain (arthralgia in 30%), bone-density loss with fracture risk, vaginal dryness, mood change. Mandatory: baseline DEXA scan + repeat every 2 years; calcium + vitamin D supplementation; consider bisphosphonate or denosumab if osteopenia.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>\u0391\u03c5\u03c4\u03cc \u03c0\u03bf\u03c5 \u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03b5\u03c4\u03b5 \u03bc\u03b5 \u03c4\u03b7\u03bd MedsBase:<\/strong> \u03a0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf\u03c2 \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ae\u03c2 WHO-GMP \u00b7 \u0394\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u00b7 \u03a0\u03b1\u03b3\u03ba\u03cc\u03c3\u03bc\u03b9\u03b1 \u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae \u00b7 1,400+ \u03b5\u03c0\u03b1\u03bb\u03b7\u03b8\u03b5\u03c5\u03bc\u03ad\u03bd\u03b5\u03c2 <a href=\"https:\/\/medsbase.com\/el\/reviews\/\">\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ad\u03c2 \u03c0\u03b5\u03bb\u03b1\u03c4\u03ce\u03bd<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd <a href=\"https:\/\/medsbase.com\/el\/medsbase-re-shipment-assurance-policy\/\"><strong>\u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/strong><\/a> \u2014 \u03b5\u03ac\u03bd \u03c4\u03bf \u03b4\u03ad\u03bc\u03b1 \u03c3\u03b1\u03c2 \u03b4\u03b5\u03bd \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03b5\u03bd\u03c4\u03cc\u03c2 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03c9\u03bd \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c4\u03bf \u03b5\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03c5\u03bc\u03b5.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 24px 0;border-radius:4px;font-size:14px;\"><strong>&#9888; Specialist supervision required.<\/strong> Cancer medications must be prescribed by a treating oncologist with a confirmed diagnosis, baseline staging, and a defined treatment plan. Never start, stop, change dose, or use cancer medication outside of an oncology-led care plan. Most cancer drugs require regular blood-test monitoring (FBC, LFT, renal function), are absolutely contraindicated in pregnancy, and have significant drug interactions.<\/div>\n<div style=\"background:#f4f8fb;border:1px solid #d6e4ec;padding:12px 18px;margin:14px 0;border-radius:4px;font-size:14px;color:#3a5160;text-align:center;\">\n<strong>\ud83d\udd12 \u039a\u03c1\u03c5\u03c0\u03c4\u03bf\u03b3\u03c1\u03b1\u03c6\u03b7\u03bc\u03ad\u03bd\u03b7 \u039f\u03bb\u03bf\u03ba\u03bb\u03ae\u03c1\u03c9\u03c3\u03b7 \u0391\u03b3\u03bf\u03c1\u03ac\u03c2<\/strong> \u00b7 <strong>\ud83d\udcb3 \u0395\u03c0\u03b1\u03bb\u03b7\u03b8\u03b5\u03c5\u03bc\u03ad\u03bd\u03bf\u03c2 \u0395\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae\u03c2<\/strong> \u00b7 <strong>\ud83d\ude9a \u03a0\u03b1\u03b3\u03ba\u03cc\u03c3\u03bc\u03b9\u03b1 \u0391\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae<\/strong> \u00b7 <strong>\u2b50 4.9\/5 \u03b1\u03c0\u03cc 1,400+ \u03c0\u03b5\u03bb\u03ac\u03c4\u03b5\u03c2<\/strong>\n<\/div>\n<h2 class=\"wp-block-heading\">What Is Anaridex?<\/h2>\n<p>Anaridex is an oral tablet from Cipla containing <strong>anastrozole 1 mg<\/strong>. Anastrozole is a third-generation, non-steroidal, selective aromatase inhibitor used for adjuvant and metastatic treatment of <strong>hormone-receptor-positive (HR+) breast cancer in postmenopausal women<\/strong>. Originally developed by AstraZeneca (brand name Arimidex), anastrozole is now a generic standard of care. It is one of the three most-prescribed aromatase inhibitors worldwide alongside <a href=\"https:\/\/medsbase.com\/el\/xtane\/\">exemestane<\/a> \u03ba\u03b1\u03b9 <a href=\"https:\/\/medsbase.com\/el\/letroheal\/\">letrozole<\/a>.<\/p>\n<h2 class=\"wp-block-heading\">How Does Anaridex Work?<\/h2>\n<p>In postmenopausal women, ovarian oestrogen production has stopped &mdash; circulating oestrogen comes almost entirely from peripheral conversion of adrenal and gonadal androgens (androstenedione, testosterone) by the enzyme <strong>aromatase<\/strong> in fat, muscle, liver and breast tissue. Anastrozole reversibly inhibits aromatase, suppressing peripheral oestrogen synthesis by approximately <strong>95%<\/strong> within 24&ndash;48 hours.<\/p>\n<ul>\n<li><strong>Selective non-steroidal aromatase inhibitor<\/strong> &mdash; competes with androgen substrate at the aromatase active site without binding the oestrogen receptor itself.<\/li>\n<li><strong>Postmenopausal-only mechanism<\/strong> &mdash; in premenopausal women, the hypothalamic-pituitary-ovarian axis compensates by raising LH\/FSH and increasing ovarian aromatase, defeating the suppression. <strong>Anastrozole is ineffective in premenopausal women.<\/strong><\/li>\n<li><strong>Reversible binding<\/strong> &mdash; effect ends within 7&ndash;10 days of discontinuation as new aromatase enzyme is synthesised.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u03a7\u03c1\u03ae\u03c3\u03b5\u03b9\u03c2 \u03ba\u03b1\u03b9 \u03b5\u03bd\u03b4\u03b5\u03af\u03be\u03b5\u03b9\u03c2<\/h2>\n<ul>\n<li><strong>Adjuvant therapy<\/strong> for early HR+ breast cancer in postmenopausal women, typically for 5 years (extended to 10 years in higher-risk disease)<\/li>\n<li><strong>First-line metastatic HR+ breast cancer<\/strong> in postmenopausal women, often combined with a CDK4\/6 inhibitor (palbociclib, ribociclib, abemaciclib)<\/li>\n<li><strong>Sequential therapy<\/strong> after 2&ndash;3 years of <a href=\"https:\/\/medsbase.com\/el\/tamilong\/\">tamoxifen<\/a>, switching to an AI for completion of 5&ndash;10 years total endocrine therapy<\/li>\n<li><strong>\u0395\u03ba\u03c4\u03cc\u03c2 \u03b5\u03bd\u03b4\u03b5\u03af\u03be\u03b5\u03c9\u03bd:<\/strong> ovulation induction in fertility (specialist use), gynaecomastia in men on testosterone (specialist), male breast cancer (rare)<\/li>\n<\/ul>\n<p>Anaridex is <strong>\u03b4\u03b5\u03bd<\/strong> indicated for: premenopausal women (use tamoxifen, or AI + ovarian suppression under specialist guidance), HR-negative breast cancer (no benefit), or non-cancer cosmetic indications.<\/p>\n<h2 class=\"wp-block-heading\">Anaridex Dosage and How to Take<\/h2>\n<p>\u03a4\u03c5\u03c0\u03b9\u03ba\u03ae \u03b4\u03cc\u03c3\u03b7: <strong>1 mg once daily<\/strong>. Typical course length:<\/p>\n<ul>\n<li><strong>Adjuvant breast cancer:<\/strong> 5 years (10 years in high-risk node-positive disease, per ATLAS \/ aTTom data extrapolated to AIs)<\/li>\n<li><strong>Metastatic breast cancer:<\/strong> until disease progression or unacceptable toxicity<\/li>\n<\/ul>\n<h3 class=\"wp-block-heading\">How to Take Anaridex Properly<\/h3>\n<ol>\n<li><strong>Take one tablet once daily<\/strong> at approximately the same time each day. Morning or evening &mdash; the half-life (~50 hours) means timing has minimal effect on steady-state levels.<\/li>\n<li><strong>With or without food.<\/strong><\/li>\n<li><strong>\u039a\u03b1\u03c4\u03b1\u03c0\u03b9\u03b5\u03af\u03c4\u03b5 \u03bf\u03bb\u03cc\u03ba\u03bb\u03b7\u03c1\u03bf \u03bc\u03b5 \u03bd\u03b5\u03c1\u03cc.<\/strong><\/li>\n<li><strong>Mandatory monitoring:<\/strong> baseline DEXA bone-density scan, repeat every 2 years. Annual cholesterol panel. Lipid management as needed.<\/li>\n<li><strong>Bone protection:<\/strong> calcium 1,000&ndash;1,200 mg\/day + vitamin D 800&ndash;2,000 IU\/day. If osteopenia at baseline or develops, add a bisphosphonate (zoledronic acid IV every 6 months) or denosumab (60 mg SC every 6 months) as standard of care.<\/li>\n<li><strong>Joint pain management:<\/strong> regular weight-bearing exercise reduces arthralgia. Paracetamol or NSAIDs for symptomatic relief. Switching to <a href=\"https:\/\/medsbase.com\/el\/letroheal\/\">letrozole<\/a> \u03ae <a href=\"https:\/\/medsbase.com\/el\/xtane\/\">exemestane<\/a> sometimes helps if anastrozole arthralgia is intolerable.<\/li>\n<li><strong>Do not stop without oncologist instruction.<\/strong> Discontinuation before completion of the planned course significantly increases recurrence risk.<\/li>\n<li><strong>Missed dose:<\/strong> if remembered same day, take it. If next day, skip and resume normally &mdash; do not double-dose.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Side Effects of Anaridex<\/h2>\n<p><strong>Common (oestrogen-deprivation symptoms):<\/strong><\/p>\n<ul>\n<li>Hot flushes and night sweats (35&ndash;40%)<\/li>\n<li>Arthralgia (joint pain, stiffness, especially morning) &mdash; 30% of patients; main cause of discontinuation<\/li>\n<li>Myalgia (muscle aches)<\/li>\n<li>Vaginal dryness, dyspareunia<\/li>\n<li>Mood changes, low energy<\/li>\n<li>Hair thinning<\/li>\n<li>Mild nausea<\/li>\n<\/ul>\n<p><strong>Important long-term:<\/strong><\/p>\n<ul>\n<li><strong>Accelerated bone-density loss<\/strong> &mdash; fracture risk increased ~30% versus tamoxifen. Mandatory DEXA monitoring and bone-protection.<\/li>\n<li>Hyperlipidaemia (small increase in total cholesterol and LDL)<\/li>\n<li>Carpal tunnel syndrome<\/li>\n<\/ul>\n<p><strong>Less common but seek review:<\/strong><\/p>\n<ul>\n<li>Ischaemic cardiac events (small absolute increase, mainly in patients with prior cardiac disease)<\/li>\n<li>Hepatotoxicity (mild LFT rises common; severe rare)<\/li>\n<li>Endometrial cancer signal &mdash; lower than with tamoxifen, slightly higher than placebo<\/li>\n<li>Severe hypersensitivity (rare)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u03a0\u03c1\u03bf\u03b5\u03b9\u03b4\u03bf\u03c0\u03bf\u03b9\u03ae\u03c3\u03b5\u03b9\u03c2 \u03ba\u03b1\u03b9 \u03c0\u03c1\u03bf\u03c6\u03c5\u03bb\u03ac\u03be\u03b5\u03b9\u03c2<\/h2>\n<ul>\n<li><strong>Pregnancy: ABSOLUTE CONTRAINDICATION.<\/strong> Anastrozole is teratogenic in animal models. Postmenopausal patients are usually past childbearing potential, but perimenopausal patients require contraception.<\/li>\n<li><strong>Premenopausal women:<\/strong> ineffective unless combined with ovarian suppression (GnRH agonist) under specialist oncologist supervision. Default to <a href=\"https:\/\/medsbase.com\/el\/tamilong\/\">tamoxifen<\/a> in premenopausal HR+ breast cancer.<\/li>\n<li><strong>Bone health:<\/strong> baseline DEXA before starting; repeat every 2 years. Calcium + vitamin D supplementation. Consider bisphosphonate or denosumab if osteopenia.<\/li>\n<li><strong>\u039a\u03b1\u03c1\u03b4\u03b9\u03b1\u03b3\u03b3\u03b5\u03b9\u03b1\u03ba\u03ac:<\/strong> small increase in ischaemic cardiac events versus tamoxifen. Address modifiable risk factors. Monitor lipids annually.<\/li>\n<li><strong>\u03a3\u03bf\u03b2\u03b1\u03c1\u03ae \u03b7\u03c0\u03b1\u03c4\u03b9\u03ba\u03ae \u03b4\u03c5\u03c3\u03bb\u03b5\u03b9\u03c4\u03bf\u03c5\u03c1\u03b3\u03af\u03b1:<\/strong> caution &mdash; limited data.<\/li>\n<li><strong>Concurrent oestrogen therapy<\/strong> (oestrogen-containing HRT or vaginal oestrogen): avoid &mdash; defeats the purpose of treatment.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u0391\u03bb\u03bb\u03b7\u03bb\u03b5\u03c0\u03b9\u03b4\u03c1\u03ac\u03c3\u03b5\u03b9\u03c2 \u03a6\u03b1\u03c1\u03bc\u03ac\u03ba\u03c9\u03bd<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">\u03a3\u03c5\u03bd\u03b4\u03c5\u03ac\u03b6\u03b5\u03c4\u03b1\u03b9 \u03bc\u03b5<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">\u0391\u03c0\u03bf\u03c4\u03ad\u03bb\u03b5\u03c3\u03bc\u03b1<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">\u03a4\u03b9 \u03bd\u03b1 \u03ba\u03ac\u03bd\u03b5\u03c4\u03b5<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Oestrogen-containing HRT or vaginal oestrogen<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Defeats anastrozole&#39;s mechanism &mdash; treatment fails<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Avoid all systemic and high-dose vaginal oestrogen. Use non-hormonal vaginal moisturisers. Specialist for low-dose vaginal oestriol if symptoms intolerable.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Tamoxifen<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Tamoxifen reduces anastrozole levels &mdash; do not combine<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Use sequentially, not concurrently.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Bisphosphonates (zoledronic acid, alendronate) or denosumab<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Synergistic bone-protection effect &mdash; standard combination<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Add when osteopenia develops on AI therapy.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Strong CYP3A4 inhibitors \/ inducers<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Modest effect on anastrozole levels &mdash; clinical significance unclear<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">No routine dose adjustment.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">CDK4\/6 inhibitors (palbociclib, ribociclib, abemaciclib)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Standard combination for first-line metastatic HR+ breast cancer<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Specialist oncology prescribing.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">\u039f\u03b4\u03b7\u03b3\u03af\u03b5\u03c2 \u0391\u03c0\u03bf\u03b8\u03ae\u03ba\u03b5\u03c5\u03c3\u03b7\u03c2<\/h2>\n<ul>\n<li>\u03a6\u03c5\u03bb\u03ac\u03be\u03c4\u03b5 \u03c3\u03b5 \u03b8\u03b5\u03c1\u03bc\u03bf\u03ba\u03c1\u03b1\u03c3\u03af\u03b1 \u03b4\u03c9\u03bc\u03b1\u03c4\u03af\u03bf\u03c5, <strong>15\u201325\u00b0C<\/strong>. Keep in original blister.<\/li>\n<li>\u039a\u03c1\u03b1\u03c4\u03ae\u03c3\u03c4\u03b5 \u03bc\u03b1\u03ba\u03c1\u03b9\u03ac \u03b1\u03c0\u03cc \u03c0\u03b1\u03b9\u03b4\u03b9\u03ac \u03ba\u03b1\u03b9 \u03ba\u03b1\u03c4\u03bf\u03b9\u03ba\u03af\u03b4\u03b9\u03b1.<\/li>\n<li>Return unused tablets to a pharmacy for disposal.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">\u03a3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ad\u03c2 \u0395\u03bd\u03b1\u03bb\u03bb\u03b1\u03ba\u03c4\u03b9\u03ba\u03ad\u03c2 \u039b\u03cd\u03c3\u03b5\u03b9\u03c2 \u03c3\u03c4\u03bf MedsBase<\/h2>\n<p>Other oncology medications stocked alongside this product:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/el\/xtane\/\"><strong>Xtane (exemestane 25 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/fempro\/\"><strong>Fempro (letrozole 2.5 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/letroheal\/\"><strong>Letroheal (letrozole 2.5 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/tamilong\/\"><strong>Tamilong (tamoxifen 10 \/ 20 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/tamodex\/\"><strong>Tamodex (tamoxifen 10 \/ 20 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/tamoxilon\/\"><strong>Tamoxilon (tamoxifen 10 \/ 20 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/cytotam\/\"><strong>Cytotam (tamoxifen 10 \/ 20 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/caditam\/\"><strong>Caditam (tamoxifen 20 mg)<\/strong><\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/medsbase.com\/el\/anti-cancer-medication\/\">Browse all anti-cancer medications &rarr;<\/a><\/p>\n<h2 id=\"faqs\">\u03a3\u03c5\u03c7\u03bd\u03ad\u03c2 \u0395\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2<\/h2>\n<h3 class=\"wp-block-heading\">Why is Anaridex only used in postmenopausal women?<\/h3>\n<p>In premenopausal women, the hypothalamic-pituitary axis responds to falling oestrogen by raising LH\/FSH and increasing ovarian aromatase, defeating the suppression. Anastrozole is therefore <strong>ineffective in premenopausal women<\/strong> as monotherapy. The standard endocrine therapy in premenopausal HR+ breast cancer is <a href=\"https:\/\/medsbase.com\/el\/tamilong\/\">tamoxifen<\/a>; in higher-risk premenopausal patients, AI + GnRH agonist (ovarian suppression) is sometimes used under specialist supervision.<\/p>\n<h3 class=\"wp-block-heading\">How long do I take Anaridex for?<\/h3>\n<p>Standard adjuvant duration is <strong>5 years<\/strong>. For higher-risk node-positive disease, extended therapy to <strong>7&ndash;10 years<\/strong> is increasingly recommended (extrapolated from ATLAS and aTTom tamoxifen data and AI extension trials such as MA.17R). For metastatic disease, anastrozole continues until progression or intolerable toxicity.<\/p>\n<h3 class=\"wp-block-heading\">How do I manage joint pain on Anaridex?<\/h3>\n<p>Aromatase inhibitor arthralgia affects ~30% of patients and is the main reason for premature discontinuation. First-line measures: regular weight-bearing exercise (yoga, walking, swimming), vitamin D 1,000&ndash;2,000 IU\/day, paracetamol or short courses of NSAIDs, weight management. If intolerable, switching to <a href=\"https:\/\/medsbase.com\/el\/letroheal\/\">letrozole<\/a> \u03ae <a href=\"https:\/\/medsbase.com\/el\/xtane\/\">exemestane<\/a> sometimes helps &mdash; about 30% of patients tolerate one AI but not another.<\/p>\n<h3 class=\"wp-block-heading\">Will Anaridex weaken my bones?<\/h3>\n<p>Yes &mdash; aromatase inhibitors accelerate bone-density loss with about <strong>30% increased fracture risk<\/strong> versus tamoxifen. Mandatory baseline DEXA scan, repeat every 2 years. Calcium + vitamin D supplementation is standard. If osteopenia develops, add a bisphosphonate (zoledronic acid IV every 6 months) or denosumab (60 mg SC every 6 months) &mdash; this is now standard of care and should be discussed with the oncologist.<\/p>\n<h3 class=\"wp-block-heading\">Can I use vaginal oestrogen for dryness while on Anaridex?<\/h3>\n<p>Generally not recommended &mdash; even low-dose vaginal oestrogen produces measurable systemic absorption that can defeat AI therapy. First-line: non-hormonal vaginal moisturisers (Replens, hyaluronic acid gels) and water-based lubricants. If symptoms are intolerable, a specialist may consider very low-dose vaginal oestriol on an individual risk-benefit basis (vaginal oestriol has lower systemic absorption than oestradiol).<\/p>\n<h3 class=\"wp-block-heading\">Anaridex vs tamoxifen vs letrozole vs exemestane &mdash; which is right for me?<\/h3>\n<p>This is an oncologist decision based on your menopausal status, tumour biology, and side-effect profile. Broad pattern: <strong>premenopausal HR+<\/strong> \u2192 <a href=\"https:\/\/medsbase.com\/el\/tamilong\/\">tamoxifen<\/a> first-line. <strong>Postmenopausal HR+<\/strong> &rarr; AI (anastrozole \/ letrozole \/ exemestane) first-line, with switch to tamoxifen as 2nd-line if AI intolerance. The three AIs have similar efficacy. Anastrozole and letrozole are non-steroidal; exemestane is steroidal and structurally distinct. Switching between AIs is reasonable for intolerable side effects.<\/p>\n<h3 class=\"wp-block-heading\">Is Anaridex safe in pregnancy?<\/h3>\n<p>Absolutely not. Anastrozole is contraindicated in pregnancy and breastfeeding. Postmenopausal patients are usually past childbearing potential, but perimenopausal patients (chemotherapy-induced amenorrhoea may not be permanent) need reliable non-hormonal contraception throughout treatment.<\/p>\n<h3 class=\"wp-block-heading\">Can I take Anaridex with my heart medications?<\/h3>\n<p>Anastrozole has minimal direct interactions with cardiovascular medications. The relevant clinical concern is the <strong>small increased risk of ischaemic cardiac events<\/strong> on AI therapy versus tamoxifen, particularly in patients with established cardiac disease. Optimise modifiable cardiac risk factors (statins for hyperlipidaemia, BP control, smoking cessation, exercise) and discuss any chest pain promptly.<\/p>\n<h3 class=\"wp-block-heading\">What happens if I stop Anaridex early?<\/h3>\n<p>Stopping adjuvant aromatase inhibitor therapy before completion of the planned 5&ndash;10 years course significantly increases breast cancer recurrence risk. Real-world data show that fewer than 50% of patients complete the full 5 years &mdash; usually because of arthralgia and quality-of-life impact. Always discuss intolerable side effects with your oncologist before stopping &mdash; switching AI, dose modifications, supportive care, and acupuncture for arthralgia are all options before discontinuation.<\/p>\n<p><!-- medsbase-why-order --><\/p>\n<h3>\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03af\u03bb\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase<\/h3>\n<p>\u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03c4\u03af\u03b4\u03b1 \u03c0\u03c1\u03bf\u03ad\u03c1\u03c7\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03ad\u03bd\u03b1 <strong>\u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf \u03b1\u03c0\u03cc \u03c4\u03b7 WHO-GMP \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ae<\/strong>. \u039f\u03b9 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b5\u03c2 \u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03b5 \u03b1\u03c0\u03bb\u03ac, \u03b1\u03c3\u03ae\u03bc\u03b1\u03bd\u03c4\u03b1 \u03c0\u03b1\u03ba\u03ad\u03c4\u03b1 \u03b1\u03c0\u03cc \u03c4\u03bf\u03c5\u03c2 \u03c3\u03c5\u03bd\u03b5\u03c1\u03b3\u03ac\u03c4\u03b5\u03c2 \u03bc\u03b1\u03c2 \u03c3\u03c4\u03b7\u03bd \u03b5\u03ba\u03c0\u03bb\u03ae\u03c1\u03c9\u03c3\u03b7 \u03ba\u03b1\u03b9 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd <a href=\"\/el\/medsbase-re-shipment-assurance-policy\/\">\u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/a>: \u03b5\u03ac\u03bd \u03ad\u03bd\u03b1 \u03b4\u03ad\u03bc\u03b1 \u03b4\u03b5\u03bd \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03b5\u03bd\u03c4\u03cc\u03c2 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03c9\u03bd \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c3\u03c4\u03ad\u03bb\u03bd\u03bf\u03c5\u03bc\u03b5 \u03bc\u03b9\u03b1 \u03b4\u03c9\u03c1\u03b5\u03ac\u03bd \u03b5\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae, \u03c7\u03c9\u03c1\u03af\u03c2 \u03b5\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Related Anti-Cancer Medications<\/h3>\n<p>Other oncology medications stocked alongside this product:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/el\/xtane\/\">Xtane (exemestane 25 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/letroheal\/\">Letroheal (letrozole 2.5 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/fempro\/\">Fempro (letrozole 2.5 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/tamilong\/\">Tamilong (tamoxifen 10\/20 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/tamodex\/\">Tamodex (tamoxifen 10\/20 mg)<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Reduces breast cancer risk<br \/>\n\u2705 Inhibits estrogen production<br \/>\n\u2705 Treats hormone receptor-positive<br \/>\n\u2705 Slows cancer progression<br \/>\n\u2705 Manages postmenopausal symptoms<\/p>\n<p><span style=\"color: #000000\">Anaridex contains <strong>Anastrozole<\/strong><\/span><\/p>","protected":false},"featured_media":55287,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3595,3141,3223],"product_tag":[3899,3900],"class_list":{"0":"post-55286","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-cancer-medication","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","9":"product_tag-anaridex","10":"product_tag-anastrozole","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product\/55286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/comments?post=55286"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media\/55287"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media?parent=55286"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_brand?post=55286"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat?post=55286"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_tag?post=55286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}